Galera C, Clemente F, Alcantara A, Trapote M A, Perea A, Lopez-Delgado M I, Villanueva-Penacarrillo M L, Valverde I
Department Metabolismo, Nutricion y Hormonas, Fundacion Jimenez Diaz, Madrid, Spain.
Cell Biochem Funct. 1996 Mar;14(1):43-8. doi: 10.1002/cbf.639.
A potent glycogenic effect of GLP-1(7-36)amide has been found in rat hepatocytes and skeletal muscle, and specific receptors for this peptide, which do not seem to be associated with the adenylate cyclase-cAMP system, have been detected in these tissue membranes. On the other hand, inositolphosphoglycan molecules (IPGs) have been implicated as second messengers of the action of insulin. In this work, we have found, in differentiated BC3H-1 myocytes, specific binding of [125I]GLP-1(7-36)amide, and a stimulatory effect of the peptide on glycogen synthesis, confirming the findings in rat skeletal muscle. Also, GLP-1(7-36)amide modulates the cell content of radiolabelled glycosylphosphatidylinositols (GPIs) and increases the production of diacylglycerol (DAG), in the same manner as insulin acts, indicating hydrolysis of GPIs and an immediate and short-lived generation of IPGs. Thus, IPGs and DAG could be mediators in the glycogenic action of GLP-1(7-36)amide in skeletal muscle.
已在大鼠肝细胞和骨骼肌中发现GLP-1(7-36)酰胺具有强大的糖原生成作用,并且在这些组织膜中检测到该肽的特异性受体,这些受体似乎与腺苷酸环化酶-cAMP系统无关。另一方面,肌醇磷酸聚糖分子(IPG)被认为是胰岛素作用的第二信使。在这项研究中,我们发现在分化的BC3H-1肌细胞中,[125I]GLP-1(7-36)酰胺存在特异性结合,并且该肽对糖原合成有刺激作用,这证实了在大鼠骨骼肌中的研究结果。此外,GLP-1(7-36)酰胺以与胰岛素相同的方式调节放射性标记的糖基磷脂酰肌醇(GPI)的细胞含量并增加二酰基甘油(DAG)的产生,表明GPI水解以及IPG的即时和短暂生成。因此,IPG和DAG可能是GLP-1(7-36)酰胺在骨骼肌中糖原生成作用的介质。